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DObjective: The purpose of this study was to evaluate the hemodynamic changes in left ventricular function
before and after patent ductus arteriosus ligation in premature infants with regard to the energetic efficiency
of left ventricular pumping.
Methods: Thirty-five premature infants who underwent patent ductus arteriosus ligation were enrolled in this
study. Left ventricular efficiency was evaluated at 4 points: within 24 hours before patent ductus arteriosus
ligation, within 24 hours after patent ductus arteriosus ligation, between postoperative days 2 and 4, and on post-
operative day 7. The indices of contractility (end-systolic elastance) and afterload (effective arterial elastance)
were approximated on the basis of the systemic blood pressure and systolic or diastolic left ventricular volume.
The ratio of stroke work and pressure-volume area, representing the ventricular efficiency, was estimated using
the following theoretic formula: the ratio of stroke work and pressure-volume area ¼ 1/(1 þ 0.5 ventriculoarte-
rial coupling).
Results: Left ventricular efficiency was transiently deteriorated within 24 hours after patent ductus arteriosus
ligation because of the marked increase of the afterload and the slight increase of contraction, and then recovered
to preoperation levels by 2 to 4 days after patent ductus arteriosus ligation.
Conclusions: Analysis of indices representing the afterload, contractility, and energetic efficiency of the left
ventricle may provide practical information for the management of premature infants during the postoperative
period after patent ductus arteriosus ligation. (J Thorac Cardiovasc Surg 2013;146:1353-8)Patent ductus arteriosus (PDA) is one of the most critical
problems of the respiratory and circulatory system that
can occur during the first few weeks after birth in premature
infants.1 The occurrence of PDA in premature infants
increases with a lower gestational age and lower birth
weight. In the EPICure cohort, the occurrence of PDA
was approximately 65% for infants who were born at less
than 28 weeks of gestational age and approximately 80%
for infants with a birth weight less than 800 g.2,3 The
first-line treatment or prophylaxis for PDA is administration
of indomethacin, and the second-line treatment is surgical
ligation. The surgical procedure has been safely carried
out by pediatric cardiothoracic surgeons; nevertheless, the
postoperative intensive management is sometimes compli-
cated because the pulmonary vascular compliance, contrac-
tion power of the cardiac muscle, and renal function are
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The Journal of Thoracic and CarFor the evaluation of the hemodynamic change before
and after PDA ligation, previous reports investigated the
left ventricular (LV) function by echocardiogram using
the indices of ejection fraction (EF), shortening fraction,
mean velocity of circumferential fiber shortening, end-
systolic wall stress, or systemic vascular resistance,5-8 or
those by tissue Doppler imaging.9 These reports demon-
strated that the increase of afterload after PDA ligation
influenced LV function.5-7 However, these reports
investigated only hemodynamic changes within 24 hours
of PDA ligation, and dynamic changes in the LV
efficiency after PDA ligation have not been sufficiently
studied. The other study using an animal model showed
that PDA ligation for premature baboon neonates
increased the afterload and decreased LV function as
evaluated by the index of shortening fraction.10 As a new
evaluation method of hemodynamics, the concept of energy
efficiency has been recently applied for patients who have
undergone cardiac surgery. The indices of end-systolic ela-
stance (Ees), effective arterial elastance (Ea), and ventricu-
loarterial coupling (Ea/Ees) were simply calculated from
blood pressure and measurements by echocardiogram, and
provided a useful framework for investigating ventricular
performance.11 With the use of these indices, previous re-
ports studied the ventricular efficiency before and after aor-
tic valve replacement12 and mitral valve surgery,13 or for
congenital heart disease.14-16 The current study evaluated
the hemodynamic changes in LV function before and afterdiovascular Surgery c Volume 146, Number 6 1353
Abbreviations and Acronyms
Ea ¼ effective arterial elastance
Ees ¼ end-systolic elastance
Ea/Ees ¼ ventriculoarterial coupling
EF ¼ ejection fraction
LV ¼ left ventricular
LVEDV ¼ left ventricular end-diastolic volume
LVEDVI ¼ left ventricular end-diastolic volume
index
LVESV ¼ left ventricular end-systolic volume
LVESVI ¼ left ventricular end-systolic volume
index
PDA ¼ patent ductus arteriosus
POD ¼ postoperative day
SD ¼ standard deviation
SW/
PVA
¼ ratio of stroke work and pressure-
volume area
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DPDA ligation in premature infants with regard to the
energetic efficiency of LV pumping.
MATERIALS AND METHODS
Patient Information
A total of 847 premature infants (gestational age<36 weeks) were ad-
mitted to Kyushu University Hospital from January 2003 to December
2010. The cases accompanied with congenital heart diseases and chromo-
somal disorders, or in poor clinical condition, such as those with severe
respiratory syndrome, bacterial sepsis, or necrotic enterocolitis, were
excluded from this study. All of the premature infants born at less than
25 weeks of gestational age without an apparently severe critical condition
were routinely administered prophylactic indomethacin 3 times after birth:
0.1 mg/kg/6 hours at 12 to 15 hours after birth, 0.1 mg/kg/6 h 24 hours after
the first administration, and 0.1 mg/kg/6 hours 24 hours after the second
administration. The infants born at 25 weeks and more than 25 weeks of
gestational age were treated with indomethacin only when clinical symp-
toms were observed, such as tachypnea, tachycardia, and a reduction of
urine output due to PDA. The dose of indomethacin was 0.1 mg/kg/6 hours;
if the PDA did not close, the same dosewas administered a second and third
time 24 hours after the first and second treatments, respectively. If the in-
domethacin treatment did not effectively close the PDA and symptomatic
heart failure persisted because of the presence of PDA, surgical PDA liga-
tion was performed. Informed consent for the surgery was obtained from
the parents of all patients. All retrospective data used in this study were
obtained by means of charts and electronic database reviews.
Surgical Technique
PDA ligation was performed using standard methods. Anesthesia was
conducted in intubated infants by a standard technique, with intravenous
infusions of fentanyl and the muscle relaxant pancuronium. The patients
were placed in a right lateral position, and a standard left posterolateral
thoracotomy was performed through the third intercostal space. A single
ligation of the PDAwas performed with a silk suture.
Analysis of Cardiovascular Function by
Echocardiogram
The LVefficiency before and after PDA ligation was evaluated by trans-
thoracic echocardiogram at 4 points: within 24 hours before PDA ligation,1354 The Journal of Thoracic and Cardiovascular Surwithin 24 hours after PDA ligation, between postoperative days (PODs) 2
and 4, and on POD 7. The LV end-diastolic volume (LVEDV) and LV
end-systolic volume (LVESV) were calculated by the Teichholz M-mode
method based on the data about the LV end-diastolic dimension and the
end-systolic dimension obtained from the echocardiogram.17 The LV
end-diastolic volume index (LVEDVI), LV end-systolic volume index
(LVESVI), and EF were calculated as follows: LVEDVI (mL/
m2) ¼ LVEDV/body surface area, LVESVI (mL/m2) ¼ LVESV/body sur-
face area, EF (%) ¼ (1-LVESV/LVEDV) 3 100. The arterial blood pres-
sure was measured by the Korotkoff technique using the manchette
method. The indices of contractility (Ees) and afterload (Ea) were calcu-
lated on the basis of the systemic blood pressure and cardiac volume
data using the approximation method, as described previously.18 The
approximation of the Ees and Ea was performed as follows: Ees ¼ mean
blood pressure /minimal LV volume; Ea¼maximal LV pressure/(maximal
LV volume  minimal LV volume). The mean blood pressure was
calculated as follows: mean blood pressure ¼ (systolic blood
pressure þ diastolic blood pressure32)/3. The maximal LV pressure was
approximated by the systolic blood pressure. The maximal LV volume
was defined as being equal to the LVEDV, and the minimal LV volume
was defined as being equal to the LVESV. The Ea/Ees indicates the ventri-
culoarterial coupling between the left ventricle and the arterial system.11
The ratio of stroke work and pressure-volume area (SW/PVA) represents
the LV efficiency, which was estimated using the theoretic formula SW/
PVA ¼ 1/(1 þ 0.5 Ea/Ees).19
Statistical Analysis
The values are presented as the mean values standard deviation (SD).
An analysis of variancewith repeated measures on 1 factor was used for the
variables measured at the 4 points (within 24 hours before PDA ligation,
within 24 hours after PDA ligation, between PODs 2 and 4, and on POD
7). The Student Newman–Keuls test was used as a post hoc test.RESULTS
Clinical Manifestations
Among the 847 premature infants, 98 were treated with in-
domethacin for the closure of or prophylaxis for PDA, and 63
of thesePDAcaseswere closedby5.8 4.1daysof age.There
were 35 patients with persistent PDA even after indomethacin
treatment, and surgical PDA ligation was performed in all of
these infants. The mean SD gestational age of these infants
was 27.2 4.4weeks, and their birthweightwas 934 499g.
Thenarrowest PDAdiameterwas 2.43 1.08mm.Theblood-
flow speed in the PDAwas 2.16 0.80 m/sec. Surgical PDA
ligation was performed at 23.5  11.6 days of age. The body
weight of the infants at PDA ligation was 978  504 g. The
length of the operation was 37.2  9.3 minutes. No critical
complications developed in any of the patients during the
operation (Table 1). Eighteen of 35 patients were treated
with dopamine or dobutamine before surgery to assist cardiac
function. After surgery, all patients, including these 18, were
given a dopamine or dobutamine infusion at a dose of 3 to 5
mg/kg/min for at least 24 hours, but vasodilating agents (eg,
phosphodiesterase 3 inhibitors) were not used. Eighteen pa-
tients were managed under mechanical ventilation before the
surgery, and all of the patients were controlled under mechan-
ical ventilation for at least 3 days after the surgery. Detailed
data on circulatory and respiratory supports for the patientsgery c December 2013
TABLE 1. Patient characteristics
Total no. N ¼ 847
Patients with PDA
Control patients
N ¼ 27Total N ¼ 98
Closed by indomethacin
N ¼ 63
Closed by ligation
N ¼ 35
Male/female 461/386 51/47 32/31 19/16 14/13
Gestational age (wk) 31.4  3.2 26.9  4.2 26.8  4.3 27.2  4.4 27.3  4.6
Birth weight (g) 1588  518 938  441 940  423 934  499 980  503
RDS (%) 197 (23.2) 57 (59.1) 46 (74.1) 12 (36.3) 14 (51.8)
CLD (%) 89 (10.5) 38 (38.7) 27 (43.1) 11 (33.3) 10 (37.0)
ICH (%) 6 (0.69) 6 (7.1) 6 (10.3) 1 (3) 2 (7.4)
NEC (%) 4 (0.48) 2 (2.0) 2 (3.4) 0 (0) 1 (3.7)
ROP (%) 13 (15.7) 40 (40.8) 27 (43.1) 13 (39.3) 13 (48.1)
Death (%) 5 (5.4) 1 (1.0) 1 (1.7) 0 (0) 0 (0)
PDA closure
Age (d) 5.8  4.1 23.5  11.6
Body weight (g) 941  445 978  504
Narrowest PDA diameter (mm) 2.43  1.08
Blood-flow speed in PDA (m/s) 2.16  0.80
Data are shown as the mean  SD. PDA, Patent ductus arteriosus; RDS, respiratory distress syndrome; CLD, chronic lung disease; ICH, intracerebral hemorrhage; NEC,
necrotizing enterocolitis; ROP, retinopathy of prematurity.
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complications occurred in any of the patients after surgery,
such as pneumothorax, chylothorax, hemothorax, hypoten-
sion, vocal cord paralysis, or infection. Clinical data, such as
blood pressure, heart rate, oxygen saturation, urine output,
and blood pH, are shown in Table 3. Soon after the operation,
the blood pressures were remarkably increased, whereas other
parameters (eg, heart rate or oxygen saturation) were not sig-
nificantly changed.
Twenty-seven premature infants, whose ductus arteriosus
was closed spontaneously, were also studied and compared
with the 35 infants in whom surgical PDA ligation was per-
formed; they are shown as control patients in Table 1. There
were no significant differences in the clinical characteristics
between them.TABLE 2. Circulatory and respiratory supports before and after patent d
Within 24 h before PDA ligation Within 2
Mean doses of catecholamines
Dopamine (mg/kg/min) 1.66  1.77 (N ¼ 18) 3.30
Dobutamine (mg/kg/min) 0.16  0.69 (N ¼ 2) 0.30
Mean doses of IV fluid
administration (mL/kg/h)
4.53  1.71 (N ¼ 35) 4.61
Mechanical ventilation (N ¼ 18)
Mean FIO2 0.24  0.05 0.25
SIMV (N ¼ 8)
RR (/min) 35.5  9.1 33.7
PIP (mm Hg) 20.1  3.60 18.9
PEEP (mm Hg) 4.84  0.80 4.90
HFO (N ¼ 10)
MAP (mm Hg) 10.2  0.63 10.2
SV (mL) 10.5  1.58 10.0
Data are presented as mean  SD. N, Number of the treated patients. PDA, patent ductus a
chronized intermittent mandatory ventilation; RR, respiratory rate; PIP, peak inspiratory
MAP, mean airway pressure; SV, stroke volume. *P<.05 versus before PDA ligation.
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The points evaluated by echocardiogramwere as follows:
within 24 hours before PDA ligation (mean SD, 8.4 5.8
hours; range, 3-21 hours), within 24 hours after PDA liga-
tion (mean  SD, 5.5  4.0 hours; range, 1-18 hours), be-
tween PODs 2 and 4 (mean  SD, 70.6  14.6 hours;
range, 49-92 hours), and on POD 7 (mean  SD,
164  2.6 hours; range, 160-169 hours). For the evaluation
at the third point (PODs 2-4), approximately two thirds of
the patients (25/35) were examined. As shown in Table 4,
the LV EF decreased significantly within 24 hours after
the operation (from 74.1%  10.2% to 63.5%  9.8%,
P< .05), but the EF recovered to the preoperation level
by PODs 2 to 4 in most patients and gradually increased
until POD 7 (75.6%  6.4% and 79.5%  7.6%,uctus arteriosus ligation
4 h after PDA ligation Postoperative days 2-4 Postoperative day 7
 0.98* (N ¼ 35) 0.36  1.12* (N ¼ 4) 0.08  0.50* (N ¼ 1)
 1.06 (N ¼ 4) 0.07  0.48 (N ¼ 1) 0.0 (N ¼ 0)
 1.71 (N ¼ 35) 4.80  1.22 (N ¼ 25) 5.76  1.22* (N ¼ 35)
(N ¼ 35) (N ¼ 17) (N ¼ 17)
 0.08 0.22  0.02 0.22  0.03
(N ¼ 24) (N ¼ 8) (N ¼ 6)
 7.9 31.2  8.7 26.7  8.7*
 4.33 15.5  4.65* 16.6  5.3
 0.42 4.63  0.67 4.60  0.69
(N ¼ 11) (N ¼ 9) (N ¼ 11)
 1.19 9.80  1.39 9.45  1.50
 1.00 9.50  1.71 9.36  1.91
rteriosus; IV, intravenous; FiO2, Fractional inspired oxygen concentration; SIMV, syn-
pressure; PEEP, positive end-expiratory pressure; HFO, high-frequency oscillation;
diovascular Surgery c Volume 146, Number 6 1355
TABLE 3. Clinical data before and after patent ductus arteriosus ligation
Within 24 h before PDA
ligation
Within 24 h after PDA
ligation Postoperative days 2-4y Postoperative day 7
Systolic BP (mm Hg) 54.6  7.89 59.1  11.9 61.4  8.46* 60.7  10.5*
Diastolic BP (mm Hg) 28.3  7.37 36.4  7.43* 37.8  7.73* 38.0  10.3*
Mean BP (mm Hg) 36.8  6.72 43.2  8.38* 45.2  6.95* 45.4  10.2*
Heart rates (beats/min) 152  8.53 153  8.79 148  8.75 148  8.50
SpO2 (%) 96.6  2.88 96.7  2.86 94.1  16.4 97.4  1.71
Blood gas data
pH 7.38  0.07 7.37  0.07 7.40  0.05 7.39  0.06
BE 1.95  4.28 1.00  4.32 3.47  3.48 1.80  2.24
Lactate (mmol/L) 1.72  0.80 1.68  0.91 1.44  0.47 0.71  1.71
Urine output (mL/kg/h) 3.37  1.30 4.05  2.27 4.21  1.49 4.45  1.46*
Data are presented as the mean  SD. PDA, Patent ductus arteriosus; BP, blood pressure; Spo2, Saturation of peripheral oxygen; BE, base excess. *P<.05 versus before PDA
ligation. yTwenty-five of 35 patients were evaluated.
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24 hours after PDA ligation (from 1.25  0.53 mm Hg/
mL/m2 to 2.66  0.96 mm Hg/mL/m2, P<.05) but gradu-
ally decreased after that time point (at PODs 2-4:
2.26  0.72 mm Hg/mL/m2, at POD 7: 2.01  0.83 mm
Hg/mL/m2). The Ees index slightly increased within 24
hours after PDA ligation, but the increase was not statisti-
cally significant (from 2.46  1.88 mm Hg/mL/m2 to
2.92  1.95 mm Hg/mL/m2), whereas the index was drasti-
cally increased at PODs 2 to 4 (4.64 1.22 mmHg/mL/m2)
and was maintained at the same level until POD 7
(4.45 2.87 mmHg/mL/m2). The SW/PVA ratio decreased
significantly within 24 hours after PDA ligation (from
76.3%  8.0% to 66.6%  11.2%), but recovered to the
preoperation level by PODs 2 to 4, and the ratio was main-
tained until POD 7 (78.7%  7.8% and 78.6%  8.2%,
respectively). All of the hemodynamic data at POD 7
were approximately the same as those of the control pa-
tients. Because the hemodynamic change within 24 hours
might be variable, we reevaluated the hemodynamic indices
in all of the patients divided by the first evaluation time
within 24 hours after PDA ligation. As a result, there
were no significant changes in the indices among the groups
(Appendix Table 1). We assessed the circulatory and respi-
ratory findings between those under myocardial depressionTABLE 4. Hemodynamic data before and after patent ductus arteriosus l
Within 24 h before
PDA ligation
Within 24 h after
PDA ligation P
LVEDVI (mL/m2) 70.8  37.9 49.6  30.3*
LVESVI (mL/m2) 21.7  15.2 22.2  16.3
EF (%) 74.1  10.2 63.5  9.8*
Ea (mm Hg/mL/m2) 1.25  0.53 2.66  0.96*
Ees (mm Hg/mL/m2) 2.46  1.88 2.92  1.95
Ea/Ees 0.64  0.28 1.10  0.57*
SW/PVA (%) 76.3  8.0 66.6  11.2*
Data are presented as the mean SD. PDA, Patent ductus arteriosus; LVEDVI, left ventricul
ejection fraction; Ea, effective arterial elastance; Ees, end-systolic elastance; Ea/Ees, ventric
versus before PDA ligation. yP<.05 versus within 24 hours after PDA ligation. zTwenty
1356 The Journal of Thoracic and Cardiovascular Sur(Ea/Ees 1.0) or not (Ea/Ees<1.0) and found that condi-
tions under circulatory and respiratory support did not
have any significant differences between the groups within
24 hours after PDA ligation (Appendix Table 2).
DISCUSSION
The presence of PDA in infants may play an important
role in their adaptation to the hemodynamic changes after
birth. The PDA can maintain adequate arterial oxygen ten-
sion20 and protect the immature ventricle against afterload
by maintaining low vascular resistance for a few hours after
delivery in premature infants.10 However, a persistent PDA
causes an inadequate blood flow balance in the pulmonary
and systemic circulation, causing various clinical problems.
PDA closure at an appropriate time is thus needed for
premature infants. Some of them require surgical interven-
tion, but postoperative LV hypofunction sometimes occurs
after PDA ligation.21 To improve the safe management of
premature infants after PDA ligation, we investigated the
time course of hemodynamic changes before and after
PDA ligation with regard to the energy efficiency of the
left ventricle.
The energetic efficiency of the heart is defined as the ratio
of stroke work (SW)22 to myocardial oxygen consumption.
The oxygen consumption is linearly correlated with theigation
ostoperative days 2-4z Postoperative day 7 Control patients
41.7  23.3* 48.0  31.1* 49.8  10.5*
12.5  8.0*,y 14.2  10.2*,y 14.9  7.4*,y
75.6  6.4y 79.5  7.6y 80.1  10.0y
2.26  0.72* 2.01  0.83* 2.11  0.77*
4.64  1.22*,y 4.45  2.87*,y 4.52  2.73*,y
0.56  0.42y 0.56  0.28y 0.55  0.23y
78.7  7.8y 78.6  8.2y 79.2  10.5y
ar end-diastolic volume index; LVESVI, left ventricular end-systolic volume index;EF,
uloarterial coupling; SW/PVA, ratio of strokework and pressure-volume area. *P<.05
-five of the 35 patients were evaluated.
gery c December 2013
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Dpressure-volume area (PVA)23; thus, the energetic effi-
ciency can be estimated from the ratio of the SW to the
PVA. The Ea/Ees represents the ventriculoarterial coupling
between the left ventricle and the arterial system, and indi-
cates the balance between contractility and afterload. The
energetic efficiency (SW/PVA) was simply calculated
from the Ea/Ees.19 Theoretic study and clinical data for
the patients with normal heart function showed that the
SW of ventricular contraction was maximized when Ea/
Ees ¼ 1 under a constant level of myocardial oxygen con-
sumption,22 whereas the energetic efficiency of ventricular
contraction was maximized when Ea/Ees¼ 0.5.11 The pres-
ent study showed that the Ea/Ees index was more than 1.0
within 24 hours after PDA ligation, indicating that the LV
efficiency was impaired soon after PDA ligation. The LV
contraction (Ees) drastically improved by 2 to 4 days after
PDA ligation, whereas the afterload (Ea) gradually recov-
ered, but was still at a higher level 7 days after ligation
than in the preoperation state. In contrast, the transient de-
terioration of the LV energy efficiency after PDA ligation
was recovered within 2 to 4 days after ligation. These
parameters made it possible to assess the hemodynamic
changes of LV contraction, afterload, and energy efficiency
separately.
In the present study, none of the 35 premature infants
showed any respiratory complications or systemic hypoten-
sion after PDA ligation. If the patients have any pre- or post-
operative complications that may affect their systemic
hemodynamics, the present data would be helpful for deter-
mining the drug indications. For example, in cases of sys-
temic hypotension within 24 hours after PDA ligation,
inotropic agents such as dopamine or epinephrine should
be used to increase LV contractility (Ees) in addition to
phosphodiesterase inhibitors to decrease the afterload
(Ea). Beginning 24 hours after PDA ligation, vasodilators
to decrease the afterload would be the essential and first-
line treatment.
Study Limitations
The findings in this study provide useful information for
the critical management of the circulatory and respiratory
conditions for premature infants after PDA ligation. How-
ever, there were several limitations to this study. First, the
accuracy of the approximation of the Ea and Ees on the
basis of echocardiography in the premature infants has
not been evaluated. Thus, a comparison of data obtained
from a catheter system24 and by echocardiography at each
time point, if possible, would be useful in a future study.
Second, we did not assess any premature infants without
PDA; therefore, further study for those will be important
to uncover the particular effect by existence of PDA. Third,
we did not take into consideration the possible modification
of the indices by anesthesia. Because the anesthetizing
agents fentanyl and pancuronium could alter the LVThe Journal of Thoracic and Carcontraction and afterload, further study to evaluate the ef-
fects of these drugs is important. In addition, we did not dis-
cuss the effect of preload because the energy efficiency of
the left ventricle (Ea, Ees) is theoretically independent of
the preload. Nevertheless, it was likely that preload could
influence the LV contraction; thus, further comprehensive
evaluation of the preload by standard methods, such as
the early and atrial mitral inflow velocities,6 in combination
with the energy efficiency would give us information to
reveal detailed cardiovascular status before and after PDA
ligation. Finally, we did not have data from a conductance
catheter technique; thus, a comparison of data obtained
from a catheter system and by echocardiography at each
time point, if possible, would be useful in a future study.CONCLUSIONS
We investigated the LV function in terms of the energetic
efficiency before and after PDA ligation. This study showed
that the LVefficiency was transiently deteriorated within 24
hours after PDA ligation because of a marked increase of
the afterload and a slight increase in contractility, and
then recovered to preoperation levels 2 to 4 days after
PDA ligation. The consecutive evaluations of the afterload,
contractility, and energetic efficiency of LV function may
provide practical information for the management for pre-
mature infants during the period after PDA ligation.
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Within 2 h
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At 2-6 h
(N ¼ 4)
At 6-9 h
(N ¼ 1)
At 12-18 h
(N ¼ 7)
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Ea/Ees 1.03  0.46 1.12  0.29 0.98 1.16  0.55
SW/PVA (%) 67.6  10.0 64.4  6.21 67.2 64.8  10.8
Data are presented as the mean  SD. Ea, Effective arterial elastance; Ees, end-
systolic elastance; Ea/Ees, ventriculoarterial coupling; SW/PVA, ratio of stroke
work and pressure-volume area.
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March 29, 2012 [Epub ahead of print].APPENDIX TABLE 2. Comparison of circulatory and respiratory
supports within 24 hours after patent ductus arteriosus ligation
between the patients with Ea/Ees 1.0 and<1.0
Ea/Ees 1.0
(N ¼ 18)
Ea/Ees<1.0
(N ¼ 17)
Mean doses of catecholamines (N) (18) (17)
Dopamine (mg/kg/min) 3.40  0.82 3.18  1.16
Dobutamine (mg/kg/min) 0.55  1.39 0.00  0.00
Mechanical ventilation (N) (18) (17)
FIO2 0.25  0.06 0.26  0.10
SIMV (N) (10) (13)
RR (/min) 31.5  7.47 35.5  8.15
PIP (mm Hg) 19.3  4.19 18.5  4.60
PEEP (mm Hg) 4.91  0.31 4.91  0.51
HFO (N) (8) (4)
MAP (mm Hg) 10.1  0.75 10.4  1.67
SV (mL) 10.5  1.04 9.40  0.54
Blood gas data
pH 7.38  0.07 7.34  0.01
BE 2.69  3.72 0.08  4.29
Lactate (mmol/L) 1.85  1.07 1.50  0.71
Data are presented as the mean SD. Ea/Ees,Ventriculoarterial coupling, N, number
of treated patients; Fio2, fractional inspired oxygen concentration; SIMV, synchro-
nized intermittent mandatory ventilation; RR, respiratory rate; PIP, peak inspiratory
pressure; PEEP, positive end-expiratory pressure; HFO, high-frequency oscillation;
MAP, mean airway pressure; SV, stroke volume; BE, base excess.
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